Corza Medical Signs Definitive Agreement to Acquire Takeda's TachoSil Manufacturing Operations
26 avr. 2023 09h03 HE
|
Corza Medical Inc.
WESTWOOD, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Corza Medical announced today that it has entered into a definitive agreement with a subsidiary of Takeda Pharmaceuticals Company...
Corza Medical kündigt Direktvertrieb von TachoSil® auf dem US-Markt an
20 avr. 2023 14h57 HE
|
Corza Medical Inc.
WESTWOOD, Massachusetts, April 20, 2023 (GLOBE NEWSWIRE) -- Corza Medical („Corza“) gab strategische Pläne bekannt, TachoSill®, ein erstklassiges chirurgisches Fibrin-Versiegelungspflaster, dem...
Corza Medical annonce une distribution directe du TachoSil® sur le marché américain
20 avr. 2023 14h57 HE
|
Corza Medical Inc.
WESTWOOD, Massachusetts, 20 avr. 2023 (GLOBE NEWSWIRE) -- Corza Medical (« Corza ») a annoncé des plans stratégiques pour vendre directement le produit TachoSil®, un patch de colle de fibrine...
Corza Medical Announces Direct Distribution of TachoSil® to the US Market
20 avr. 2023 09h05 HE
|
Corza Medical Inc.
WESTWOOD, Mass., April 20, 2023 (GLOBE NEWSWIRE) -- Corza Medical (“Corza”) announced strategic plans to directly sell TachoSil®, a best-in-class surgical fibrin sealant patch trusted by medical...